1. Data provided by Global Sales Inc., UCB and J&J.
2. GaBI Online - Biosimilars of adalimumab [www.gabionline. net]. Mol, Belgium: Pro Pharma Communications International; [cited 2016 Aug 1]. Available at: http://www.gabion- line.net/Biosimilars/General/Biosimilars-of-adalimumab.
3. Storz U., IP issues of therapeutic antibodies, in: Intellectual Property Issues: Therapeutics, Vaccines and Molecular Diagnostics, Storz U., Flasche W. and Driehaus J., eds, Springer.
4. Claims to antibodies not adequately described by disclosing known antigens to which they bind;Xue;J Intellect Prop Law Pract,2011